BRPI0415480A - composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia - Google Patents

composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia

Info

Publication number
BRPI0415480A
BRPI0415480A BRPI0415480-0A BRPI0415480A BRPI0415480A BR PI0415480 A BRPI0415480 A BR PI0415480A BR PI0415480 A BRPI0415480 A BR PI0415480A BR PI0415480 A BRPI0415480 A BR PI0415480A
Authority
BR
Brazil
Prior art keywords
nutritional composition
side effects
composition against
radiotherapy side
against chemotherapy
Prior art date
Application number
BRPI0415480-0A
Other languages
English (en)
Inventor
Eduardo Schiffrin
Denis Breuille
Stephanie Blum-Sperisen
Anne Donnet-Hughes
Magali Faure
Claudia Roessle
Marco Enrico Turini
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0415480A publication Critical patent/BRPI0415480A/pt
Publication of BRPI0415480B1 publication Critical patent/BRPI0415480B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO NUTRICIONAL CONTRA EFEITOS COLATERAIS DE QUIMIOTERAPIA OU RADIOTERAPIA". A presente invenção refere-se a uma composição nutricional adequada para pacientes que sofrem quimioterapia e/ou radiação tais como pacientes com câncer. A composição, que pode estar em forma de pó ou líquida, compreende proteínas de trigo e caseína, TGF-<225> e glutamina livre.
BRPI0415480-0A 2003-10-16 2004-10-14 Composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia BRPI0415480B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03023383 2003-10-16
EP03023383.7 2003-10-16
PCT/EP2004/011539 WO2005039318A1 (en) 2003-10-16 2004-10-14 Nutritional composition against side effects of chemotherapy of radiotherapy

Publications (2)

Publication Number Publication Date
BRPI0415480A true BRPI0415480A (pt) 2006-12-26
BRPI0415480B1 BRPI0415480B1 (pt) 2019-09-17

Family

ID=34354470

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415480-0A BRPI0415480B1 (pt) 2003-10-16 2004-10-14 Composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia

Country Status (14)

Country Link
US (1) US7468193B2 (pt)
EP (1) EP1675480B1 (pt)
JP (2) JP5473190B2 (pt)
CN (1) CN1889856B (pt)
AR (1) AR046184A1 (pt)
BR (1) BRPI0415480B1 (pt)
CA (1) CA2542652C (pt)
CO (1) CO5690615A2 (pt)
ES (1) ES2677868T3 (pt)
IL (1) IL175081A0 (pt)
MY (1) MY148289A (pt)
TW (1) TW200526134A (pt)
WO (1) WO2005039318A1 (pt)
ZA (1) ZA200603886B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2382874A1 (en) 2003-06-23 2011-11-02 Nestec S.A. Amino acid supplementation for a healthy microbiota ecosystem
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
CA2666871C (en) * 2006-10-19 2011-08-30 Nestec S.A. Long term feed - cancer patient
AU2007312284B2 (en) * 2006-10-19 2011-03-03 Société des Produits Nestlé S.A. Long-term feed - elderly
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
EP2818055B1 (en) * 2007-12-05 2020-10-28 N.V. Nutricia High energy liquid enteral nutritional composition
CN101939011B (zh) 2008-02-07 2012-10-10 雀巢产品技术援助有限公司 用于影响由剧烈的体力活动中恢复的组合物和方法
RU2011115184A (ru) * 2008-09-19 2012-10-27 Нестек С.А. (Ch) Питательная поддержка для предупреждения или ослабления паралича костного мозга или нейтропении во время противораковой терапии
MX2011002984A (es) * 2008-09-19 2011-08-08 Nestec Sa Soporte nutricional para pevenir y/o moderar la toxicidad de medula osea a partir de un tumor canceroso.
US8350006B2 (en) 2008-10-24 2013-01-08 Mead Johnson Nutrition Company Methods for determining the bioactivity of TGF-β in a composition
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8367354B2 (en) 2008-10-24 2013-02-05 Mead Johnson Nutrition Company Methods for determining the levels of TGF-β in a composition
EP2411137B1 (en) 2009-03-27 2016-09-07 Bend Research, Inc. Spray-drying process
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
JP2011201842A (ja) * 2010-03-26 2011-10-13 Kobayashi Pharmaceutical Co Ltd 腸由来細胞の増殖促進剤
WO2012031133A2 (en) 2010-09-03 2012-03-08 Bench Research, Inc. Spray-drying apparatus and methods of using the same
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
US20130280225A1 (en) * 2010-12-29 2013-10-24 Nestec S.A. Fiber and probiotics for reducing intestinal symptoms related to stress
CN103402532B (zh) * 2011-03-04 2015-01-28 丘比株式会社 肠内营养剂
WO2012141575A1 (en) 2011-04-14 2012-10-18 N.V.Nutricia Combination of epa, dpa and/or dha with a chemotherapeutic agent
US20120269929A1 (en) * 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
US8765201B2 (en) * 2011-06-08 2014-07-01 Creneau Creations, Inc. High calorie food product and method
DK2734049T3 (en) 2011-06-20 2018-07-30 Heinz Co Brands H J Llc PROBIOTIC COMPOSITIONS AND PROCEDURES
FR2979241B1 (fr) * 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
US9693958B2 (en) 2013-03-15 2017-07-04 Cureport, Inc. Methods and devices for preparation of lipid nanoparticles
PL2994150T3 (pl) 2013-05-10 2019-09-30 H.J. Heinz Company Brands Llc Probiotyki i sposoby zastosowania
US20210169104A1 (en) * 2014-08-11 2021-06-10 Six Sigma Laboratories Llc Oral rehydration composition
WO2016067132A1 (en) 2014-10-31 2016-05-06 Bend Research Inc. Process for forming active domains dispersed in a matrix
EP3294279B1 (en) 2015-05-14 2020-01-01 Professional Dietetics S.p.A. Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
MX2020001765A (es) 2017-08-14 2020-07-29 Axcella Health Inc Composiciones de aminoacidos para el tratamiento de enfermedad hepatica.
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
CA3118336A1 (en) * 2018-11-01 2020-05-07 Societe Des Produits Nestle S.A. Hard non-dairy cheese composition and process for preparation thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
US5824297A (en) 1990-06-25 1998-10-20 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
AUPN271295A0 (en) 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
EP0527283B1 (en) * 1991-08-12 1997-11-26 Societe Des Produits Nestle S.A. Food composition
ES2243965T3 (es) 1996-07-09 2005-12-01 Societe Des Produits Nestle S.A. Procedimiento de secado mediante pulverizacion.
DK0862863T4 (da) 1997-01-09 2008-12-01 Nestle Sa Kornprodukt indeholdende probiotika
CA2223198A1 (en) * 1997-01-14 1998-07-14 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
AUPP327198A0 (en) 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
JP2001128615A (ja) * 1999-11-04 2001-05-15 Ajinomoto Co Inc 乳幼児用調整粉乳
FR2802212B1 (fr) 1999-12-13 2002-03-01 Agronomique Inst Nat Rech Procede pour l'obtention d'une poudre contenant des micro-organismes viables, poudre obtenue selon ce procede et dispositif pour sa mise en oeuvre
AU7659601A (en) * 2000-08-07 2002-02-18 Discovery Life Pty Ltd Managing a life insurance investment
EP1609468A3 (en) * 2000-11-22 2006-01-25 Rxkinetix, Inc. A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis
US8227448B2 (en) * 2000-12-27 2012-07-24 N.V. Nutricia Nutritional composition with health promoting action containing oligosaccharides
DE60231809D1 (pt) 2001-02-19 2009-05-14 Nestle Sa
EP1420811A2 (en) 2001-04-10 2004-05-26 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
MXPA03009772A (es) * 2001-04-24 2004-02-23 Gen Hospital Corp Metodos y composiciones para tratar lesiones orales y del esofago.
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients

Also Published As

Publication number Publication date
WO2005039318A1 (en) 2005-05-06
JP2007508343A (ja) 2007-04-05
JP2012211139A (ja) 2012-11-01
BRPI0415480B1 (pt) 2019-09-17
ZA200603886B (en) 2007-11-28
CN1889856A (zh) 2007-01-03
JP5473190B2 (ja) 2014-04-16
EP1675480B1 (en) 2018-06-13
CO5690615A2 (es) 2006-10-31
CA2542652A1 (en) 2005-05-06
CN1889856B (zh) 2011-03-02
US20070042021A1 (en) 2007-02-22
ES2677868T3 (es) 2018-08-07
IL175081A0 (en) 2006-08-20
AR046184A1 (es) 2005-11-30
EP1675480A1 (en) 2006-07-05
TW200526134A (en) 2005-08-16
MY148289A (en) 2013-03-29
CA2542652C (en) 2014-05-13
US7468193B2 (en) 2008-12-23

Similar Documents

Publication Publication Date Title
BRPI0415480A (pt) composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia
BRPI0511967A (pt) usos de derivados de 5-amino-2,4,7-trioxo-3,4,7,8-tetrahidro-2h-pirido[2,3-d] pirimidina e compostos relacionados para o tratamento de cáncer, suas composições farmacêuticas, embalagens comerciais e respectivo kit
BRPI0616987A2 (pt) pirazolopirimidinas como inibidores de cinase dependente de ciclina
IL186104A (en) Phosphoramidate History of Nucleoside Compounds
BRPI0923786C8 (pt) compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos e composições farmacêuticas compreendendo ditos compostos
SG163583A1 (en) Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
ECSP088350A (es) Pirazolopirimidinas como inhibidores de protein quinasas
BR112019010020A2 (pt) compostos com atividade anti-tumoral contra células cancerosas contendo mutações de egfr ou her2 exon 20
MX2009013729A (es) Imidazopirazinas como inhibidores de proteina quinasa.
PT1951730E (pt) Derivados de pirimidina ligados a heteroalquilo
MX2009003778A (es) Alimentacion a largo plazo para paciente de cancer.
MX2009005011A (es) Imidazopirazinas como inhibidores de proteina quinasa.
BRPI0507644A (pt) pirazolopirimidinas como inibidores de cinase dependente de ciclina
MY155710A (en) Composition for regulating lipid metabolism
BRPI0606891A2 (pt) anticorpos dr5 e usos dos mesmos
TW200621804A (en) Ctla-4 antibody and aromatase inhibitor combination treatment for breast cancer
GEP20115283B (en) Pyrrolopyrimidine compounds and their uses
NO20090348L (no) Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av samme
UA97795C2 (uk) Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки
UA100540C2 (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
MX2009004623A (es) Imidazopiridazinas como inhibidores de la lipido cinasa pi3k.
BR112013004436A2 (pt) composições e usos de materiais com atividade microbicida alta e toxicidade baixa
BRPI0610786B8 (pt) uso de um ou mais oligossacarídeos ácidos e neutros, e cisteína e/ou fonte de cisteína, e, composição alimentícia
MY148723A (en) Use of pinolenic acid for the treatment of obesity
UA99434C2 (ru) Применение производных алкилфосфолипидов со сниженной цитотоксичностью

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 33/19 (2016.01), A23L 33/00 (2016.01)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/09/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/09/2019, OBSERVADAS AS CONDICOES LEGAIS

B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2640 DE 10-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.